Pfizer India Reports Rise In Q3 Net Profit
Pfizer Ltd, the Indian unit of drug maker Pfizer Inc (NYSE: PFE), reported a 2.7% surge in its Q3 net profit.
Pfizer India's net profit for the period rose to INR482.8 million ($9.81 million), from INR469.9 million versus the previous three-month period. Its net sales dropped 7.4% to INR2.52 billion versus the previous three-month period.
Its total expenses declined 8.3% to INR2.21 billion versus INR2.41 billion.
PFE shares closed at $21.48 on Friday.







